Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.37
(
0.16%
)
Bitcoin
78,087.87
(
-0.24%
)
News Focus
News Focus
Post# of 704047
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jeffsaxx

Send PM Follow Ignore
Followers 14
Posts 1957
Boards Moderated 0
Alias Born 06/26/2003

jeffsaxx

Re: dec212012 post# 437498

Tuesday, 11/15/2005 12:06:32 PM

Tuesday, November 15, 2005 12:06:32 PM

Post# of 704047
ELN --- J D Edwards' estimate of 7% of US market and 6% of European market is pathetically skinny when you realize that the PML scare in Feb 2005 has by subsequent investigation revealed CONCLUSIVELY that there were NO PML CASES RESULTING FROM TYSABRI MONOTHERAPY IN ALL CLINICAL DATA. If the drug is remarketed, the monotherapy usage alone will far surpass the J D Edwards estimates of market share. JMO
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today